Evolent Health, Inc. (NYSE:EVH) will look for acquisition opportunities. Seth Blackley, Chief Executive Officer said, During 2022, we'll continue to evaluate other strategic accretive acquisition opportunities. Given our market leadership position and high demand in the market, we continue to see particularly interesting opportunities to deepen and broaden the New Century platform through continued M&A.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.5 USD | -2.11% | -0.64% | -10.84% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.84% | 3.43B | |
+3.81% | 32.45B | |
+12.62% | 7.26B | |
+21.16% | 3.84B | |
-26.84% | 1.31B | |
-34.31% | 1.11B | |
+3.03% | 919M | |
-23.74% | 856M | |
-38.17% | 840M | |
-17.37% | 712M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Evolent Health to Seek Acquisition Opportunities